tiprankstipranks
Trending News
More News >
Prothena (PRTA)
NASDAQ:PRTA
US Market
Advertisement

Prothena (PRTA) Technical Analysis

Compare
667 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
6Neutral
0Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Prothena’s (PRTA) Moving Averages Convergence Divergence (MACD) indicator is 0.33, suggesting Prothena is a Buy.
Prothena’s (PRTA) 20-Day exponential moving average is 10.07, while Prothena’s (PRTA) share price is $10.48, making it a Buy.
Prothena’s (PRTA) 50-Day exponential moving average is 9.36, while Prothena’s (PRTA) share price is $10.48, making it a Buy.

Prothena (PRTA) Pivot Points

Oct 31, 2025, 05:07 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
9.94
10.14
10.39
10.59
10.85
11.05
11.30
Fibonacci
10.14
10.31
10.42
10.59
10.77
10.88
11.05
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Prothena (PRTA) Moving Averages

Oct 31, 2025, 05:07 PM
Period
Simple
Exponential
MA5
10.37Buy
10.41Buy
MA10
10.20Buy
10.29Buy
MA20
10.19Buy
10.07Buy
MA50
9.26Buy
9.36Buy
MA100
7.95Buy
8.98Buy
MA200
9.61Buy
10.36Buy
Prothena’s (PRTA) 10-Day exponential moving average is 10.29, while Prothena’s (PRTA) share price is $10.48, making it a Buy.
Prothena’s (PRTA) 100-Day exponential moving average is 8.98, while Prothena’s (PRTA) share price is $10.48, making it a Buy.
Prothena’s (PRTA) stock price is $10.48 and Prothena’s (PRTA) 50-day simple moving average is 9.26, creating a Buy signal.
Prothena’s (PRTA) stock price is $10.48 and Prothena’s (PRTA) 100-day simple moving average is 7.95, creating a Buy signal.
Prothena’s (PRTA) stock price is $10.48 and Prothena’s (PRTA) 200-day simple moving average is 9.61, creating a Buy signal.

Prothena (PRTA) Technical Indicators

Oct 31, 2025, 05:07 PM
Name
Value
Implied Action
RSI (14)
59.95
Neutral
STOCH (9,6)
44.53
Neutral
STOCHRSI (14)
45.51
Neutral
MACD (12,26)
0.33
Buy
ADX (14)
44.54
Neutral
Williams %R
-58.17
Buy
CCI (14)
96.30
Neutral
ATR (14)
0.52
-
Ultimate Oscillator
40.04
Neutral
ROC
4.28
Buy
Prothena’s (PRTA) Relative Strength Index (RSI) is 59.95, creating a Neutral signal.
Prothena’s (PRTA) Trend Strength Indicator (ADX) is 44.54, creating a Neutral signal.
Prothena’s (PRTA) Commodity Channel Index (CCI) is 96.30, creating a Neutral signal.
Prothena’s (PRTA) Price Rate of Change (ROC) is 4.28, creating a Buy signal.

FAQ

Is PRTA a Buy, Hold, or Sell?
Based on PRTA’s technical indicators, PRTA is a Strong Buy.
    What is PRTA’s RSI (14)?
    PRTA’s RSI (14) is 59.95, which suggests PRTA is a Neutral.
      What is PRTA’s MACD?
      PRTA’s MACD is 0.33, which suggests PRTA is a Buy.
        What is PRTA’s 5-day moving average?
        PRTA’s 5-day moving average is 10.37, which suggests PRTA is a Buy.
          What is PRTA’s 20-day moving average?
          PRTA 20-day moving average is 10.19, which suggests PRTA is a Buy.
            What is PRTA’s 50-day moving average?
            PRTA’s 50-day moving average is 9.26, which suggests PRTA is a Buy.
              What is PRTA’s 200-day moving average?
              PRTA’s 200-day moving average is 9.61, which suggests PRTA is a Buy.
                What is PRTA’s Williams % R (14)?
                PRTA’s Williams % R (14) is -58.17, which suggests PRTA is a Buy.
                  What is PRTA’s CCI (14)?
                  PRTA’s CCI (14) is 96.30, which suggests PRTA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis